CTCA Home Infusion Program Provides Patient-Centered Cancer Care
Chevon Rariy, MD, discusses how the 2019 coronavirus disease pandemic impacted the uptake of telehealth and the creation of the Home Infusion Program, which allows cancer patients to continue their treatment at home while quarantining himself.
Chevon Rariy, MD, medical director of endocrinology at the Cancer Treatment Centers of America (CTCA) Chicago, and director of the CTCA’s telehealth program, explains how the 2019 coronoavirus disease (COVID-19) pandemic had an impact on the adoption of telehealth and the creation of the home infusion program, which allows cancer patients to continue their treatment at home while being in quarantine.
Telehealth has become vital during the COVID-19 pandemic, according to Rariy, as social distancing has been put in place. It enabled the transition of the modern healthcare system to a virtual environment. This innovation, crucial during the pandemic, could help redefine what cancer care will look like in the future.
Even slight delays in treatment can impact mortality or symptom management, according to Rariy. The home infusion program allows patients to receive chemotherapy at home while using telehealth for follow-up appointments. This allows the patient to maintain a social distance while respecting their treatment schedule.